This today from the Singapore Straits Times seems to be a follow up piece here about this development –
http://meltwaternews.com/prerobot/sph.asp?pub=ST&sphurl=www.straitstimes.com//Singapore/Story/STIStory_543329.html
“It was also found that MAPK13 plays a role in allowing the tumour cells to move and invade normal organ tissues.
The discovery means the enzyme could complement the current biomarkers used to diagnose bile duct cancer.
‘This is significant as it is now possible to deactivate the gene through treatment to slow down the cancerous growth,’ Prof Teh, who is also the director of the NCCS-Vari team, told The Straits Times.”
Gavin